MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy
- PMID: 21827757
- DOI: 10.1016/j.febslet.2011.07.042
MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy
Abstract
Diabetic nephropathy (DN) is a major diabetic complication. However, the initiating molecular events triggering DN are unknown. In this study we focused on microRNA-451 (miR-451), which is downregulated during early DN. We found that miR-451 negatively regulated the expression of Ywhaz through Ywhaz 3'UTR and that Ywhaz was required for the miR-451-mediated downregulation of p38 MAPK signalling. Moreover, over-expression of miR-451 inhibits glomerular mesangial cell proliferation in vitro and in vivo. These findings suggest that the growth-inhibitory effect of miR-451 may be explained in part by miR-451-induced suppression of Ywhaz and p38 MAPK signalling, providing evidence for the potential role of miR-451 in early DN.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.FEBS Lett. 2009 Jun 18;583(12):2009-14. doi: 10.1016/j.febslet.2009.05.021. Epub 2009 May 19. FEBS Lett. 2009. PMID: 19450585
-
The Long Noncoding RNA 150Rik Promotes Mesangial Cell Proliferation via miR-451/IGF1R/p38 MAPK Signaling in Diabetic Nephropathy.Cell Physiol Biochem. 2018;51(3):1410-1428. doi: 10.1159/000495590. Epub 2018 Nov 28. Cell Physiol Biochem. 2018. PMID: 30485837
-
Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.Acta Diabetol. 2013 Dec;50(6):965-9. doi: 10.1007/s00592-013-0492-8. Acta Diabetol. 2013. PMID: 23797704
-
Role of growth arrest-specific gene 6 in diabetic nephropathy.Vitam Horm. 2008;78:375-92. doi: 10.1016/S0083-6729(07)00015-5. Vitam Horm. 2008. PMID: 18374201 Review.
-
Study of microRNA in diabetic nephropathy: isolation, quantification and biological function.Nephrology (Carlton). 2015 Mar;20(3):132-9. doi: 10.1111/nep.12374. Nephrology (Carlton). 2015. PMID: 25487691 Review.
Cited by
-
Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease.Kidney Res Clin Pract. 2018 Sep;37(3):197-209. doi: 10.23876/j.krcp.2018.37.3.197. Epub 2018 Sep 30. Kidney Res Clin Pract. 2018. PMID: 30254844 Free PMC article. Review.
-
Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1.J Diabetes Complications. 2014 May-Jun;28(3):259-64. doi: 10.1016/j.jdiacomp.2014.01.002. Epub 2014 Jan 11. J Diabetes Complications. 2014. PMID: 24560136 Free PMC article.
-
Towards microRNA-based therapeutics for diabetic nephropathy.Diabetologia. 2013 Mar;56(3):444-56. doi: 10.1007/s00125-012-2768-x. Epub 2012 Nov 8. Diabetologia. 2013. PMID: 23135222
-
MicroRNA-451a overexpression induces accelerated neuronal differentiation of Ntera2/D1 cells and ablation affects neurogenesis in microRNA-451a-/- mice.PLoS One. 2018 Nov 21;13(11):e0207575. doi: 10.1371/journal.pone.0207575. eCollection 2018. PLoS One. 2018. PMID: 30462722 Free PMC article.
-
Altered expression of 14-3-3ζ protein in spinal cords of rat fetuses with spina bifida aperta.PLoS One. 2013 Aug 6;8(8):e70457. doi: 10.1371/journal.pone.0070457. Print 2013. PLoS One. 2013. PMID: 23936434 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases